GRANT PICKERING - 21 Jun 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Signature
Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
21 Jun 2022
Net transactions value
-$215,639
Form type
4
Filing time
23 Jun 2022, 17:48:39 UTC
Previous filing
27 May 2022
Next filing
28 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $114,736 -5,451 -0.77% $21.05 700,005 21 Jun 2022 Direct F1, F2, F3
transaction PCVX Common Stock Sale $26,492 -1,261 -0.18% $21.01 698,744 22 Jun 2022 Direct F1, F4
transaction PCVX Common Stock Sale $74,410 -3,541 -0.51% $21.01 695,203 23 Jun 2022 Direct F1, F5
holding PCVX Common Stock 355,660 21 Jun 2022 By Children's Trusts
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $21.00 to $21.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes 1,562 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.
F4 The price reported is a weighted-average price. The shares were sold at prices ranging from $21.00 to $21.065. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 The price reported is a weighted-average price. The shares were sold at prices ranging from $21.00 to $21.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.